PTIX
Protagenic Therapeutics, Inc.\new
Key Financials
Operating Income
$-5700950
↓ 25.9%
Revenue
$0
NaN%
Total Assets
$2.0M
↓ 54.8%
Shareholders' Equity
$1.0M
↓ 72.4%
Net Income
$-5525344
↓ 10.5%
EPS (Diluted)
$-1.13
↑ 1.7%
Total Liabilities
$942759.00
↑ 43.9%
Cash & Equivalents
$671091.00
↓ 16.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PTIX |
| Company Name | Protagenic Therapeutics, Inc.\new |
| CIK | 1022899 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | DE |
| Phone | (212) 994-8200 |